Found 0 matching trials
Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL) PHASE1 This is a phase 1/2 multicenter study to assess the safety and effectivenes...
Show More Location
Center for Lymphoid Malignancies at CUMC
Learn More & Join Trial
Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma PHASE2 This phase II trial investigates how well brentuximab vedotin and nivolumab...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas PHASE3 This is a double-blind, randomized, multicenter, phase 3 clinical trial to ...
Show More Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma PHASE2 This phase II trial evaluates how well AVD (doxorubicin, vinblastine, dacar...
Show More Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Learn More & Join Trial
Brentuximab Vedotin in Early Diffuse Cutaneous Systemic Sclerosis PHASE2 The purpose of this study is to assess feasibility, safety and preliminary ...
Show More Location
Rheumatology Clinic, St. Joseph's Health Care
Learn More & Join Trial
Phase II Trial of BrECADD in HIV-Positive Patients With Advanced-Stage Classical Hodgkin Lymphoma PHASE2 Participants receive chemotherapy with BrECADD in standard doses and cycle ...
Show More Location
Multiple Locations
Learn More & Join Trial
Real-life Efficacy and Toxicity of Brentuximab-Vedotin Associated With Bendamustine in Patients With Relapsed or Refractory Hodgkin Lymphoma (HL-R2-B2) N/A Approximately 20% of patients diagnosed with Hodgkin lymphoma will eventual...
Show More Location
CH de la Côte Basque, service Hématologie Clinique
Learn More & Join Trial
Brentuximab Vedotin and Lenalidomide in Patients With Relapsed/ Refractory T-cell Lymphoma or Hodgkin Lymphoma PHASE1 This study is investigating the combination of Brentuximab vedotin and lena...
Show More Location
Peter MacCallum Cancer Centre
Learn More & Join Trial
A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma N/A Participants with CD30-positive lympoma will be treated with brentuximab ve...
Show More Location
Anhui Provincial Cancer Hospital
Learn More & Join Trial
Brentuximab Vedotin (SGN-35) in Transplant Eligible Patients With Relapsed or Refractory Hodgkin Lymphoma PHASE2 The purpose of this study is determine if 2 cycles of SGN-35 can be used in...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial